Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

On this episode of The Balancing Act, we’re covering nutritious recipes with Rock Garden and discussing unique treatment options for children suffering from ADHD and more. Plus, we’re learning all about the apple industry in New York.

First, we take a tasty trip to the Empire State, where a collective of 145 New York family farms is dedicated to introducing the most flavorful varieties of apples for consumers. Crunch Time Apple Growers’ newest varieties are SnapDragon and RubyFrost apples, which were created by Dr. Susan Brown of Cornell University to provide an apple that was easier to grow for farmers. The upside is that the farmers get a better return on their crop, while consumers enjoy an amazingly consistent eating experience.

A chef would be lost without fresh ingredients! That’s why celebrity chef Ralph Pagano is turning to the experts at Rock Garden, a South Florida-based supplier of herbs and microgreens. Join Ralph in the kitchen as he cooks up a slate of tasty recipes with Rock Garden, including salads topped with various herbs, and mushroom ravioli with sautéed sage butter, classic mojito, and infused oils.

As a parent, it’s heart-wrenching to watch your child struggle. But with patience and an effective plan, children will succeed! That’s why we’re sitting down with Rebecca Jackson from Brain Balance Achievement Centers, which offers various programs with a unique whole-child approach that is non-medical, drug-free, and helping kids get back on track!

Health, Wealth, Beauty, and Business

Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]

iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.

There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.

Comments

comments